baber/WOPTO huggingface dataset:
Patent NZ-548271-A (NZ)
Title: Prostaglandin nitrooxyderivatives
Inventor: ONGINI ENNIO
IPC: A61P27/06
Filed: 2004-12-27
Abstract: Prostaglandin nitrooxyderivatives having improved pharmacological activity and enhanced tolerability are disclosed. These prostaglandin nitrooxyderivatives can be employed for the treatment of glaucoma and ocular hypertension. These compounds are particularly suitable for the reduction of intraocular pressure in patients with open-angle glaucoma or with chronic angle-closure glaucoma who underwent peripheral iridotomy or laser iridoplasty.
Patent NZ-550827-A (NZ)
Title: Toilet seat lifter with ground level pedal connected via flexible thread to curved mount on rear of toilet seat
Inventor: WARREN MARK AIDEN TEMPLE
Filed: 2006-10-27
Abstract: Pedal 1 is connected to flexible thread 9 which is connected to curved mount 2 which is fastened to the rear of toilet seat 4. When a male user depresses pedal 1 the seat 4 is lifted.
Patent NZ-551141-A (NZ)
Title: Use of polyester powder in a laser sintering layer-by-layer process for producing a three dimensional article
Inventor: FELDKAMPSTRASSE ULRICH
Filed: 2006-11-08
Abstract: Disclosed is a layer-by-layer process for production of a three-dimensional component using powder, in which regions of the respective powder layer are selectively melted via input of electromagnetic energy, wherein the powder comprises at least one polyester prepared via polycondensation of a di- or polyhydric aliphatic alcohol and of an aliphatic diacid.
Patent NZ-552291-A (NZ)
Title: Benzimidazole anthelmintic tablet formulation
Inventor: AL ALAWI FADIL
Filed: 2006-12-21
Abstract: Disclosed is a tablet formulated for administration to an animal characterised in that the tablet includes at least one substituted or unsubstituted benzimidazole compound and characterised in that the benzimidazole compound has anthelmintic activity and is present in the tablet as micronised particles. The preferred benzimidazole compound or compounds are selected from: albendazole, ricobendazole, fenbendazole, oxfenbendazole, parbendazole, triclabendazole and combinations, analogues and derivatives thereof.
Patent NZ-563596-A (NZ)
Title: Crystalline form of tiotropium bromide anhydrate
Inventor: POP MIHAELA MARIA
IPC: A61K31/46
Filed: 2006-04-21
Abstract: Disclosed is a crystalline tiotropium bromide anhydrate characterized by the X-ray structure as defined in the specification. Also disclosed is the use of the above crystalline form for treating respiratory complaints such as asthma and COPD. Also disclosed is a method of preparing the above crystalline form.
Patent NZ-566062-A (NZ)
Title: Pharmaceutical compositions for the treatment of inner ear disorders comprising an arylcycloalkylamine such as ketamine and a biocompatible polymer
Inventor: MEYER THOMAS
IPC: A61K31/137
Filed: 2005-09-28
Abstract: Disclosed is the use of a composition containing (i) a pharmaceutically active agent selected from a group consisting of an arylcycloalkylamine (such as 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone (ketamine)) or a pharmaceutically active salt thereof, wherein the arylcycloalkyamine is an NMDA receptor antagonist, and (ii) a biocompatible polymer or a combination of biocompatible polymers for the preparation of a medicament for treating inner ear diseases. Also disclosed is the above use, wherein the medicament is formed as a release-of-drug-formulation which releases the pharmaceutically active agent over several hours up to several weeks. The use of the above composition for the preparation of a medicament for the treatment of tinnitus, hearing loss, inner ear inflammations or infections, auto-immune disorders, vertigo or Meniere's Disease is further disclosed, as is the use of a medicament for the treatment of excitotoxicity-induced ear cell degeneration or age-induced ear cell degeneration.
Patent NZ-574843-A (NZ)
Title: Association of a sinus node if current inhibitor and a beta blocker
Inventor: LEREBOURS PIGEONNIERE GUY
IPC: A61P9/10
Filed: 2009-02-12
Abstract: Disclosed is an association of the sinus node If current inhibitor ivabradine, or 3-{ 3-[{ [(7S)-3,4-dimethoxybicyclo[4.2.0]-octa-1,3,5-trien-7-yl]methyl} (methyl)amino]propyl} -7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, or one of its hydrates, crystalline forms or addition salts of any thereof with a pharmaceutically acceptable acid and a beta-blocker which is atenolol or one of its hydrates, crystalline forms or addition salts with a pharmaceutically acceptable acid or bisoprolol or one of its hydrates, crystalline forms or addition salts with a pharmaceutically acceptable acid. Also disclosed is a pharmaceutical composition comprising the association and the use of the association or the pharmaceutical composition for the manufacture of a medicament for the treatment of angina pectoris, ischaemia and heart failure.
Patent NZ-576145-A (NZ)
Title: A container
Inventor: KESSELL MICHAEL ROSS
IPC: B65D77/20
Filed: 2004-12-23
Abstract: 1. A container 1 including a) at least one side wall 4 5 6 7 and b) a basal wall, the side wall 4 5 6 7 and basal wall surrounding c) a containment region, the containment region including an upper opening at least partially surrounded by a flange disposed at the ends of the side walls 4 5 6 7) distal from the basal wall, d) the side walls 4 5 6 7) including a region of concertina 14 whereby, upon the squeezing of the side walls), the basal wall of the container 1 is compacted more, relative to the extent of the upper opening 10.
Patent NZ-579238-A (NZ)
Title: Activation of human antigen-presenting cells through clec-6
Inventor: BANCHEREAU JACQUES F
IPC: C07K14/705
Filed: 2008-02-22
Abstract: Disclosed are antibodies directed against the C-type lectin-like receptor 6 (CLEC-6). The antibodies are used for activating antigen presenting cells. CLEC-6 is synonymous with CLEC4D (C-type lectin domain family 4 member D) and CLECSF8 (C-type lectin superfamily member 8).
Patent NZ-585372-A (NZ)
Title: An adjustable mounting bracket for a drawer
Inventor: WOODALL STEPHEN ALLAN
IPC: A47B88/04
Filed: 2010-05-14
Abstract: An adjustable mounting bracket for a drawer is disclosed. The adjustable mounting bracket comprises a front support and a pair of side supports. Each side support is connected to the front support at a mounting portion adapted to provide adjustment of the position of the front support in relation to the side supports. A first slot extends at an angle of between 0° and 10° to the plane of the side supports and a second slot extends at an angle of between 35° and 45° to the plane of the side supports.
Patent NZ-587427-A (NZ)
Title: A helmet with an inflatable cells or pockets formed from layered high and low density materials
Inventor: MILSOM TOM
IPC: A42B3/12
Filed: 2009-01-19
Abstract: On the inner side of an outer shell is at least one inflatable element connected with inflation means. The element has cells of pockets for pressurisation or pressure-release. The cells contain a high density impact-absorbing foam layer of 200-300kg/m2, and a relatively low density material foam layer of 20-50kg/m2.
Patent NZ-588680-A (NZ)
Title: Granular fertilizer compositions containing particulate reactive phosphate rock (RPR) and finely ground triple superphosphate (TSP)
Inventor: HALL ROBERT HAMILTON
IPC: C05G3/90
Filed: 2008-10-20
Abstract: Disclosed is a soil treatment composition in pressed granular form as a fertiliser for application onto or into soil, said soil treatment composition including at least two active soil treatment components, one of said at least two active soil treatment components including particulate reactive phosphate rock (RPR), said reactive phosphate rock component being finely ground to particles having a predetermined median particle size less than 0.25millimetres; and said soil treatment composition also including finely ground Triple SuperPhosphate (TSP); said finely ground RPR and TSP being intimately mixed with added moisture and wherein in pressed granular form the finely ground particulate TSP in intimate contact with the finely ground particulate RPR operating to bind the components of the granular soil composition and contributing to dispersion of the components of the granular soil composition when applied to the soil.
Patent NZ-588993-A (NZ)
Title: A structure to keep the flatness of a door using magnets to selectivly release areas from the underlying foam
Inventor: JAMES ARTHUR HECKLER
IPC: F25D11/00
Filed: 2010-11-04
Abstract: A door (10) for an appliance is disclosed. The door (10) is constructed to resist deformation caused by insulation filler (7) shrinking. The door (10) has a front (2) and a rear (6) with a filler material (7) filling the gap in between. An intermediate layer (8) is bonded to the filler material (7) with the font (2) and the intermediate layer (8) being attracted by magnetic force. The intermediate layer (8) could be a permanent sheet magnet. If the filler material (7) shrinks during its cure period the intermediate layer (8) will release the front (2) allowing it to maintain its shape.
Patent NZ-594289-A (NZ)
Title: Anti-tilt mechanism for mobile shelving including track with channel and perpendicular recesses
Inventor: PARKER BRIAN MAURICE
IPC: A47B53/00
Filed: 2008-08-18
Abstract: A track assembly for mobile shelving. The track (12) includes a central channel (80) along which a roller (69) of a runner can move and perpendicular recesses (84) to either side of the channel to locate shoulders (64) of an end bracket attached to the runner to prevent a shelving unit from titling.
Patent NZ-597458-A (NZ)
Title: Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
Inventor: LANGE EINAR TONNES
IPC: C07K16/10
Filed: 2010-07-03
Abstract: 597458 Disclosed is at least one immunogen, which induces antibodies that stabilise association of the C5 domain of HIV gp120 with the transmembrane domain of gp41 and/or with the constant C2 domain of gp120 for use in reducing and/or delaying pathological effects of human 5 immunodeficiency virus I (HIV) in a human infected with HIV. Further disclosed is the use of at least one immunogen, which induces antibodies that stabilise association of the C5 domain of HIV gp120 with the transmembrane domain of gp41 and/or with the constant C2 domain of gp120 for the manufacture of a medicament for reducing and/or delaying pathological effects of human immunodeficiency virus I (HIV) in a human infected with HIV.
Patent NZ-598500-A (NZ)
Title: Method and apparatus for simultaneous localization and mapping of mobile robot environment
Inventor: EMMERICH MARK
IPC: G01C21/00
Filed: 2010-08-31
Abstract: 598500 Disclosed is a system for identifying and marking dynamic areas of a map of a physical environment of a mobile device (A). The system includes a data acquisition system that generates data identifying the mobile devices (A) physical environment. Also included is a processing apparatus, responsive to the data acquisition system. The acquisition system maps or models the mobile devices (A) physical environment and the data acquisition system's location within the mobile devices (A) physical environment in a cell-based grid. Cells are assigned probabilities indicating certainty about whether the physical space corresponding to a cell is occupied by an object or contains empty space. The processing apparatus includes an apparatus that assigns and updates probabilities to each cell within the grid map from the data generated by the data acquisition system and determines if changes in a cell's probability of occupancy indicate that a cell currently identified as empty has become occupied or a cell currently identified as occupied has become empty. These cells are marked so as not to be updated with regard to their probability of containing an obstacle or not while the probability is changing.
Patent NZ-599901-A (NZ)
Title: Improved medicinal aerosol formulations
Inventor: FUEG LISE-MARIE
IPC: A61K9/00
Filed: 2010-10-15
Abstract: Abstract 599901 The present disclosure provides a medicinal aerosol suspension formulation for MDl administration, comprising: a) micronized formoterol fumarate or a pharmaceutically acceptable salt thereof; b) micronized fluticasone propionate or a pharmaceutically acceptable salt thereof; c) a sub-therapeutic quantity of a moisture-scavenger excipient comprising sodium cromolyn; and d) a HFA propellant; wherein (a), (b) and (c) and their respective relative amounts are selected such that they associate to form floccules having a density substantially the same as that of the HFA propellant.
Patent NZ-600328-A (NZ)
Title: Baking pan with molds that allow baked goods to be grouped or formed into numbers or letter or characters
Inventor: KASTROUNIS STACEY
IPC: A21B3/13
Filed: 2010-12-01
Abstract: 600328 The present invention relates to a baking pan that includes baking cavities having base and side surfaces shaped to form baked food items of either linear or curved shape making it possible to assemble a number of such shaped baked food items to form letters of the alphabet and/or numerals. The baking pan includes a plurality of baking cavities connected to each other via a connecting portion. Each baking cavity includes a base surface, a side wall that is upstanding from the base surface and that is attached to the connecting portion. The base surface and the side surface of a first one of the baking cavities being shaped to form a baking cavity for forming a substantially linear shaped baked food item. The side surface and the base surface of a second one of the baking cavities being shaped to form a baking cavity for forming a substantially curve shaped baked food item. The present invention also relates to a method of forming baked food items of either linear or curved shape making it possible to assemble a number of such shaped baked food items to form letters of the alphabet and/or numerals.
Patent NZ-602090-A (NZ)
Title: Peptide sequences and compositions
Inventor: STOLOFF GREGORY ALAN
IPC: A61K38/01
Filed: 2008-09-05
Abstract: Patent No. 602090 Disclosed is a polypeptide composition comprising one or more polypeptides, which one or more polypeptides comprise between 8 and 75 amino acids, and which one or more polypeptides comprise: a polypeptide sequence QYSMECLEAAEPKYLDGLKTLADETAQC, or sub-sequences from this sequence which are functional fragments, the sub-sequences having 7 amino acids or more, wherein the one or more polypeptides, or sub-sequences from this sequence, elicits an immune response in vertebrates against two or more pathogens or pathogen strains responsible for an arthropod borne disease.
Patent NZ-605400-A (NZ)
Title: Chimeric clotting factors
Inventor: SALAS JOE
IPC: C12N9/96
Filed: 2011-07-11
Abstract: Discloses a chimeric clotting factor comprising: i) a clotting factor selected from the group consisting of Factor VII (FVII), Factor XI (FIX) and Factor X (FX); ii) a targeting moiety configured to bind to platelets; iii) a scaffold moiety; and iv) optionally, a spacer moiety between the clotting factor and the targeting moiety.
Patent NZ-607257-A (NZ)
Title: System and method for detecting amyloid proteins
Inventor: HARTUNG PAUL D
IPC: A61B5/00
Filed: 2011-08-12
Abstract: Disclosed is a device for detecting an amyloid protein in an eye of a mammal, the device comprising: - a light source configured to emit light to illuminate the eye with at least one of a wavelength of light, a polarisation of light or a combination thereof, each appropriate to produce fluorescence in at least an amyloid-binding compound, which has been introduced to the eye, when the amyloid-binding compound is bound to the amyloid protein, and specifically binding to the amyloid protein indicative of the amyloidogenic disorder; and - an optical unit configured to receive light including fluorescence produced as a result of the illumination of the eye and to determine a time decay rate of fluorescence for at least the fluorescence produced by the amyloid-binding compound bound to the amyloid protein, the determining permitting distinguishing of the presence of the amyloid-binding compound bound to the amyloid protein in the eye based at least on the time decay rate; and - the device comprising a photo detector unit for detecting fluorescence emitted from the eye and a time correlation single photon count module receiving electrical signals from the photo detector unit indicative of photon counts of fluoresced light from the eye.
Patent NZ-607387-A (NZ)
Title: Electric fence system and components thereof
Inventor: WOODHEAD ROBERT CHARLES BRYAN
IPC: H05C1/00
Filed: 2008-08-26
Abstract: Disclosed is a method of controlling interference in an electric fence system that includes an energiser module for applying high voltage energiser pulses to an electric fence, a monitoring module for monitoring the applied high voltage energiser pulses and a controller for controlling the energiser module and monitoring module. The method includes the steps of: a. monitoring the electric fence with the monitoring module to detect high voltage energiser pulses; b. analysing the high voltage energiser pulses; and c. using the analysis to control the generation of high voltage energiser pulses applied to the electric fence by the energiser module so as to reduce the interference.
Patent NZ-612162-A (NZ)
Title: Method of scale inhibition
Inventor: NOTTE PATRICK PIERRE
IPC: C09K8/528
Filed: 2007-05-25
Abstract: Disclosed is a method for treating water to inhibit scale formation which comprises adding a threshold amount of a scale inhibiting agent. The scale inhibiting agent is an aminoacid alkylphosphonic acids.
Patent NZ-617405-A (NZ)
Title: Dietary supplement for managing gut health
Inventor: MATHARU KAWAL
IPC: A61P31/04
Filed: 2012-05-16
Abstract: Disclosed is a dietary supplement comprising: a kiwifruit extract derived from processed kiwifruit pulp without the seeds, wherein the kiwifruit extract comprises at least one cysteine protease enzyme; an extract comprising an amylase inhibitor and/or a bifunctional proteaseamylase inhibitor which binds loosely to the cysteine protease enzyme(s) of the kiwifruit extract; and one or more suitable diluents, carriers and/or excipients.
Patent NZ-623656-A (NZ)
Title: Anti-αβtcr antibody
Inventor: SNELL DANIEL
IPC: C07K16/28
Filed: 2012-09-12
Abstract: Disclosed is a humanised monoclonal antibody specific for the human αβTCR/CD3 complex which comprises a heavy chain variable region comprising an amino acid sequence selected from the group consisting of the sequences set forth as SEQ ID NOs: 7, 12, 13, 15 and 16, and a light chain variable region comprising the amino acid sequence set forth as SEQ ID NO: 14, wherein the sequences are as disclosed in the complete specification. Also disclosed is the use of said antibody in in the manufacture of a medicament for use in suppressing a T cell mediated response in a subject.
Patent NZ-707097-A (NZ)
Title: A tap mixer assembly and a cartridge for same
Inventor: YONGHUA TANG
IPC: F16K11/074
Filed: 2015-04-16
Abstract: The present invention relates to a tap mixer assembly and a cartridge for same. The cartridge and tap mixer assembly has particular application to the mixing of hot and cold water and attempts to address the problem where the supply of cold water to the tap mixer assembly is at a higher pressure than the supply of hot water. The cartridge has a first and second valve disc, the former being rotatable, via a lever, relative to the latter, which in turn is fixed relative to the control cartridge to control the temperature of the mixed water. Inlet and outlet apertures for the hot and cold water are positioned about the perimeter and the centre portion respectively of the second valve disc. The inlet and outlet apertures for the hot water are larger than those for the cold water to offset the higher pressure at which the cold water is delivered.
Patent NZ-708537-A (NZ)
Title: Method for the preparation of human albumin with reduced level of dissolved oxygen
Inventor: JORQUERA NIETO JUAN IGNACIO
IPC: C07K14/765
Filed: 2015-05-27
Abstract: The present invention relates to a method for the preparation of a solution of human albumin, more particularly it relates to a method comprising a stage of reduction of the dissolved oxygen in said solution of albumin until a concentration equal to or less than 0.5 ppm. With the method of the present invention it is possible to obtain a solution of human albumin having a redox state closer to the redox state of the albumin present in human plasma.
Patent NZ-716016-A (NZ)
Title: A method for producing solvent from biomass
Inventor: MEDOFF MARSHALL
IPC: C12P7/16
Filed: 2012-12-20
Abstract: Disclosed is a method of producing butanol comprising: producing fructose by saccharifying a biomass and contacting the saccharifed biomass with a microorganism/enzyme isomerization agent (e.g., xylose isomerase) to convert the fructose to butanol. The fructose produces triglycerides which protect the microorganism during the fermentation process.
Patent NZ-721687-A (NZ)
Title: Stabilized stannous compositions
Inventor: REYNOLDS ERIC CHARLES
IPC: A61K8/24
Filed: 2014-12-24
Abstract: The present invention relates to improved complexes of amorphous calcium phosphate and/or amorphous calcium fluoride phosphate stabilised by phosphopeptides/phosphoproteins by addition of stannous ions. These complexes have anticariogenic properties useful to protect tooth structures as they remineralize (repair) early stages of dental caries and have other dental/medical applications (including anti-calculus, anti-erosion/corrosion and anti-dentinal hypersensitivity). Methods of making the complexes of the invention and of treatment or prevention of various dental conditions including dental caries, dental calculus, dental erosion/corrosion and dental hypersensitivity are also provided.
Patent NZ-726115-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C13K1/02
Filed: 2012-06-07
Abstract: A method comprising: a. wet milling a reduced recalcitrance (e.g. treated with an electron beam) lignocellulosic material (e.g. wood or municipal solid waste) and applying a jet mixer during wet milling; b. adding an enzyme to the reduced recalcitrance lignocellulosic material after wet milling to saccharify it; and c. adding a microorganism to the reduced recalcitrance lignocellulosic material after wet milling has been completed, to give a fermentation product such as ethanol. Wet-milling may be performed using a rotor/stator head, such as one including nesting rings of teeth.
Patent NZ-729399-A (NZ)
Title: Automatic thermal print on demand produce labeler
Inventor: HOWARTH M
IPC: B65C9/46
Filed: 2015-10-02
Abstract: An automatic, thermal print on demand labeler is provided. The thermal print head is placed above the axis of rotation of the rotary head, with a cylindrical platen mounted horizontally opposite the print head. A stripper pin is mounted between the platen and bellows arranged to receive the label; the pin is positioned very close to the print region of the print head. This positioning of components results in a label being printed and dispensed onto the bellows in one index of the multi-bellow rotary head. Independent direct gear drive trains are provided for the rotary head and label tape drive. The labeller is high speed and low cost.
Patent NZ-735710-A (NZ)
Title: Composition for preventing or treating valve calcification, containing dpp-4 inhibitor
Inventor: SAHMIN LEE
IPC: A61K31/4985
Filed: 2015-02-27
Abstract: The present invention relates to a composition for preventing or treating valve calcification, containing a dipeptidyl peptidase-4 (DPP-4) inhibitor. The DPP-4 inhibitor according to the present invention may include all of what can inhibit the expression of DPP-4 nucleotides or the activity of DPP-4 proteins, wherein: DPP-4 antibodies, sitagliptin, vildagliptin, saxagliptin, linagliptin, dutogliptin, gemigliptin, alogliptin, Anagliptin, evogliptin, Berberine, Diprotin, or Lupeol; DPP-4 mRNA anti-sense nucleotides, aptamers, small interfering RNA (siRNA), short hairpin RNA (shRNA), and microRNA (miRNA), or RNA interference (RNAi); or the like can be used.